Frontiers in Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1013352, encodeId=bba7101335213, content=有谁近期关于医学的,写中国医院投稿过的，都一头棒据掉吗，还是也有审稿的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef9a5219936, createdName=14779ba9m13暂无昵称, createdTime=Wed Sep 01 02:15:38 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013153, encodeId=75be10131536f, content=偏重的研究方向：肿瘤 经验分享：期刊对创新性要求高嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Aug 31 11:21:27 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012560, encodeId=bea6101256028, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cd52485833, createdName=1246a6fdm27暂无昵称, createdTime=Sun Aug 29 14:23:23 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974186, encodeId=bbc59e4186d7, content=请问接收付完款后状态多久会改变呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5Rzft24cdjpft6PcWribvIeHZAd5rYELzpKhbFYdIicZfcDx0zFI7AmAHIcLNgb43KDWCg0nWcgic0Ape/0, createdBy=bcf42056335, createdName=157****3710, createdTime=Wed Jun 16 20:25:37 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010704, encodeId=5d0b1010e041a, content=请问各位有遇到过，投稿界面已经显示接收了，但是仍然没有收到邮件的情况吗？这两者之间会有延迟吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Us0GFMljsgJU8D7ARU18PgytwJjuyDS9CkTgwbYCsmj14TKlf7Hrx3T5lUvwLOoibhyXiaicME34sxTOpa0ibcic7bg/132, createdBy=628b5361344, createdName=阿标2359, createdTime=Mon Aug 23 20:09:19 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009177, encodeId=9fce10091e764, content=偏重的研究方向：肿瘤 经验分享：请问大家，两个review is ongoing是指有两个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Wed Aug 18 16:40:48 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007220, encodeId=1982100e22037, content=各位大佬们，生信分析+一点临床测序的数据，可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Aug 12 10:29:26 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973820, encodeId=5e5e9e38203b, content=接受到在online请问要多久？最近需要一篇文章，不知道能不能来得及。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210614/2fd7d17bfe3e4ff9897456da2862f2bc/5d601b07dfb64fdf863f473a3f3d0cf0.jpg, createdBy=102e2533312, createdName=请叫我小硕, createdTime=Tue Jun 15 18:29:15 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007332, encodeId=e98d100e332fa, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享： 04 Aug 2021 Typesetting initiated. Production Office Frontiers Production Office uploaded file(s). 03 Aug 2021 Article accepted for publication. 02 Aug 2021 Review of Review Editor 1 finalized. 28 Jul 2021 Review of Review Editor 3 finalized. 20 Jul 2021 Submitting Author re-submitted manuscript. You posted new comments. 21 Jun 2021 Interactive review forum activated. 30 Apr 2021 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8e85475215, createdName=神力武叨叨, createdTime=Thu Aug 12 17:32:09 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003043, encodeId=525e100304377, content=请问一直在Editorial Assignment 这个状态多久才能催稿啊，一直没有分配编辑，给哪个邮箱发邮件催啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28125557864, createdName=ms5000002114037359, createdTime=Tue Jul 27 16:22:48 CST 2021, time=2021-07-27, status=1, ipAttribution=)]

2021-09-01 14779ba9m13暂无昵称

有谁近期关于医学的,写中国医院投稿过的，都一头棒据掉吗，还是也有审稿的？

36 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1013352, encodeId=bba7101335213, content=有谁近期关于医学的,写中国医院投稿过的，都一头棒据掉吗，还是也有审稿的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef9a5219936, createdName=14779ba9m13暂无昵称, createdTime=Wed Sep 01 02:15:38 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013153, encodeId=75be10131536f, content=偏重的研究方向：肿瘤 经验分享：期刊对创新性要求高嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Aug 31 11:21:27 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012560, encodeId=bea6101256028, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cd52485833, createdName=1246a6fdm27暂无昵称, createdTime=Sun Aug 29 14:23:23 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974186, encodeId=bbc59e4186d7, content=请问接收付完款后状态多久会改变呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5Rzft24cdjpft6PcWribvIeHZAd5rYELzpKhbFYdIicZfcDx0zFI7AmAHIcLNgb43KDWCg0nWcgic0Ape/0, createdBy=bcf42056335, createdName=157****3710, createdTime=Wed Jun 16 20:25:37 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010704, encodeId=5d0b1010e041a, content=请问各位有遇到过，投稿界面已经显示接收了，但是仍然没有收到邮件的情况吗？这两者之间会有延迟吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Us0GFMljsgJU8D7ARU18PgytwJjuyDS9CkTgwbYCsmj14TKlf7Hrx3T5lUvwLOoibhyXiaicME34sxTOpa0ibcic7bg/132, createdBy=628b5361344, createdName=阿标2359, createdTime=Mon Aug 23 20:09:19 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009177, encodeId=9fce10091e764, content=偏重的研究方向：肿瘤 经验分享：请问大家，两个review is ongoing是指有两个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Wed Aug 18 16:40:48 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007220, encodeId=1982100e22037, content=各位大佬们，生信分析+一点临床测序的数据，可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Aug 12 10:29:26 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973820, encodeId=5e5e9e38203b, content=接受到在online请问要多久？最近需要一篇文章，不知道能不能来得及。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210614/2fd7d17bfe3e4ff9897456da2862f2bc/5d601b07dfb64fdf863f473a3f3d0cf0.jpg, createdBy=102e2533312, createdName=请叫我小硕, createdTime=Tue Jun 15 18:29:15 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007332, encodeId=e98d100e332fa, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享： 04 Aug 2021 Typesetting initiated. Production Office Frontiers Production Office uploaded file(s). 03 Aug 2021 Article accepted for publication. 02 Aug 2021 Review of Review Editor 1 finalized. 28 Jul 2021 Review of Review Editor 3 finalized. 20 Jul 2021 Submitting Author re-submitted manuscript. You posted new comments. 21 Jun 2021 Interactive review forum activated. 30 Apr 2021 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8e85475215, createdName=神力武叨叨, createdTime=Thu Aug 12 17:32:09 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003043, encodeId=525e100304377, content=请问一直在Editorial Assignment 这个状态多久才能催稿啊，一直没有分配编辑，给哪个邮箱发邮件催啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28125557864, createdName=ms5000002114037359, createdTime=Tue Jul 27 16:22:48 CST 2021, time=2021-07-27, status=1, ipAttribution=)]

2021-08-31 Doctorfan

偏重的研究方向：肿瘤
经验分享：期刊对创新性要求高嘛

36 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1013352, encodeId=bba7101335213, content=有谁近期关于医学的,写中国医院投稿过的，都一头棒据掉吗，还是也有审稿的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef9a5219936, createdName=14779ba9m13暂无昵称, createdTime=Wed Sep 01 02:15:38 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013153, encodeId=75be10131536f, content=偏重的研究方向：肿瘤 经验分享：期刊对创新性要求高嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Aug 31 11:21:27 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012560, encodeId=bea6101256028, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cd52485833, createdName=1246a6fdm27暂无昵称, createdTime=Sun Aug 29 14:23:23 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974186, encodeId=bbc59e4186d7, content=请问接收付完款后状态多久会改变呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5Rzft24cdjpft6PcWribvIeHZAd5rYELzpKhbFYdIicZfcDx0zFI7AmAHIcLNgb43KDWCg0nWcgic0Ape/0, createdBy=bcf42056335, createdName=157****3710, createdTime=Wed Jun 16 20:25:37 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010704, encodeId=5d0b1010e041a, content=请问各位有遇到过，投稿界面已经显示接收了，但是仍然没有收到邮件的情况吗？这两者之间会有延迟吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Us0GFMljsgJU8D7ARU18PgytwJjuyDS9CkTgwbYCsmj14TKlf7Hrx3T5lUvwLOoibhyXiaicME34sxTOpa0ibcic7bg/132, createdBy=628b5361344, createdName=阿标2359, createdTime=Mon Aug 23 20:09:19 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009177, encodeId=9fce10091e764, content=偏重的研究方向：肿瘤 经验分享：请问大家，两个review is ongoing是指有两个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Wed Aug 18 16:40:48 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007220, encodeId=1982100e22037, content=各位大佬们，生信分析+一点临床测序的数据，可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Aug 12 10:29:26 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973820, encodeId=5e5e9e38203b, content=接受到在online请问要多久？最近需要一篇文章，不知道能不能来得及。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210614/2fd7d17bfe3e4ff9897456da2862f2bc/5d601b07dfb64fdf863f473a3f3d0cf0.jpg, createdBy=102e2533312, createdName=请叫我小硕, createdTime=Tue Jun 15 18:29:15 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007332, encodeId=e98d100e332fa, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享： 04 Aug 2021 Typesetting initiated. Production Office Frontiers Production Office uploaded file(s). 03 Aug 2021 Article accepted for publication. 02 Aug 2021 Review of Review Editor 1 finalized. 28 Jul 2021 Review of Review Editor 3 finalized. 20 Jul 2021 Submitting Author re-submitted manuscript. You posted new comments. 21 Jun 2021 Interactive review forum activated. 30 Apr 2021 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8e85475215, createdName=神力武叨叨, createdTime=Thu Aug 12 17:32:09 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003043, encodeId=525e100304377, content=请问一直在Editorial Assignment 这个状态多久才能催稿啊，一直没有分配编辑，给哪个邮箱发邮件催啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28125557864, createdName=ms5000002114037359, createdTime=Tue Jul 27 16:22:48 CST 2021, time=2021-07-27, status=1, ipAttribution=)]

2021-08-29 1246a6fdm27暂无昵称

没投过

33 0

[GetPortalCommentsPageByObjectIdResponse(id=1013352, encodeId=bba7101335213, content=有谁近期关于医学的,写中国医院投稿过的，都一头棒据掉吗，还是也有审稿的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef9a5219936, createdName=14779ba9m13暂无昵称, createdTime=Wed Sep 01 02:15:38 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013153, encodeId=75be10131536f, content=偏重的研究方向：肿瘤 经验分享：期刊对创新性要求高嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Aug 31 11:21:27 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012560, encodeId=bea6101256028, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cd52485833, createdName=1246a6fdm27暂无昵称, createdTime=Sun Aug 29 14:23:23 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974186, encodeId=bbc59e4186d7, content=请问接收付完款后状态多久会改变呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5Rzft24cdjpft6PcWribvIeHZAd5rYELzpKhbFYdIicZfcDx0zFI7AmAHIcLNgb43KDWCg0nWcgic0Ape/0, createdBy=bcf42056335, createdName=157****3710, createdTime=Wed Jun 16 20:25:37 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010704, encodeId=5d0b1010e041a, content=请问各位有遇到过，投稿界面已经显示接收了，但是仍然没有收到邮件的情况吗？这两者之间会有延迟吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Us0GFMljsgJU8D7ARU18PgytwJjuyDS9CkTgwbYCsmj14TKlf7Hrx3T5lUvwLOoibhyXiaicME34sxTOpa0ibcic7bg/132, createdBy=628b5361344, createdName=阿标2359, createdTime=Mon Aug 23 20:09:19 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009177, encodeId=9fce10091e764, content=偏重的研究方向：肿瘤 经验分享：请问大家，两个review is ongoing是指有两个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Wed Aug 18 16:40:48 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007220, encodeId=1982100e22037, content=各位大佬们，生信分析+一点临床测序的数据，可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Aug 12 10:29:26 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973820, encodeId=5e5e9e38203b, content=接受到在online请问要多久？最近需要一篇文章，不知道能不能来得及。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210614/2fd7d17bfe3e4ff9897456da2862f2bc/5d601b07dfb64fdf863f473a3f3d0cf0.jpg, createdBy=102e2533312, createdName=请叫我小硕, createdTime=Tue Jun 15 18:29:15 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007332, encodeId=e98d100e332fa, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享： 04 Aug 2021 Typesetting initiated. Production Office Frontiers Production Office uploaded file(s). 03 Aug 2021 Article accepted for publication. 02 Aug 2021 Review of Review Editor 1 finalized. 28 Jul 2021 Review of Review Editor 3 finalized. 20 Jul 2021 Submitting Author re-submitted manuscript. You posted new comments. 21 Jun 2021 Interactive review forum activated. 30 Apr 2021 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8e85475215, createdName=神力武叨叨, createdTime=Thu Aug 12 17:32:09 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003043, encodeId=525e100304377, content=请问一直在Editorial Assignment 这个状态多久才能催稿啊，一直没有分配编辑，给哪个邮箱发邮件催啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28125557864, createdName=ms5000002114037359, createdTime=Tue Jul 27 16:22:48 CST 2021, time=2021-07-27, status=1, ipAttribution=)]

2021-06-16 157****3710

请问接收付完款后状态多久会改变呢

45 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1013352, encodeId=bba7101335213, content=有谁近期关于医学的,写中国医院投稿过的，都一头棒据掉吗，还是也有审稿的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef9a5219936, createdName=14779ba9m13暂无昵称, createdTime=Wed Sep 01 02:15:38 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013153, encodeId=75be10131536f, content=偏重的研究方向：肿瘤 经验分享：期刊对创新性要求高嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Aug 31 11:21:27 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012560, encodeId=bea6101256028, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cd52485833, createdName=1246a6fdm27暂无昵称, createdTime=Sun Aug 29 14:23:23 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974186, encodeId=bbc59e4186d7, content=请问接收付完款后状态多久会改变呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5Rzft24cdjpft6PcWribvIeHZAd5rYELzpKhbFYdIicZfcDx0zFI7AmAHIcLNgb43KDWCg0nWcgic0Ape/0, createdBy=bcf42056335, createdName=157****3710, createdTime=Wed Jun 16 20:25:37 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010704, encodeId=5d0b1010e041a, content=请问各位有遇到过，投稿界面已经显示接收了，但是仍然没有收到邮件的情况吗？这两者之间会有延迟吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Us0GFMljsgJU8D7ARU18PgytwJjuyDS9CkTgwbYCsmj14TKlf7Hrx3T5lUvwLOoibhyXiaicME34sxTOpa0ibcic7bg/132, createdBy=628b5361344, createdName=阿标2359, createdTime=Mon Aug 23 20:09:19 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009177, encodeId=9fce10091e764, content=偏重的研究方向：肿瘤 经验分享：请问大家，两个review is ongoing是指有两个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Wed Aug 18 16:40:48 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007220, encodeId=1982100e22037, content=各位大佬们，生信分析+一点临床测序的数据，可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Aug 12 10:29:26 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973820, encodeId=5e5e9e38203b, content=接受到在online请问要多久？最近需要一篇文章，不知道能不能来得及。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210614/2fd7d17bfe3e4ff9897456da2862f2bc/5d601b07dfb64fdf863f473a3f3d0cf0.jpg, createdBy=102e2533312, createdName=请叫我小硕, createdTime=Tue Jun 15 18:29:15 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007332, encodeId=e98d100e332fa, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享： 04 Aug 2021 Typesetting initiated. Production Office Frontiers Production Office uploaded file(s). 03 Aug 2021 Article accepted for publication. 02 Aug 2021 Review of Review Editor 1 finalized. 28 Jul 2021 Review of Review Editor 3 finalized. 20 Jul 2021 Submitting Author re-submitted manuscript. You posted new comments. 21 Jun 2021 Interactive review forum activated. 30 Apr 2021 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8e85475215, createdName=神力武叨叨, createdTime=Thu Aug 12 17:32:09 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003043, encodeId=525e100304377, content=请问一直在Editorial Assignment 这个状态多久才能催稿啊，一直没有分配编辑，给哪个邮箱发邮件催啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28125557864, createdName=ms5000002114037359, createdTime=Tue Jul 27 16:22:48 CST 2021, time=2021-07-27, status=1, ipAttribution=)]

2021-08-23 阿标2359

请问各位有遇到过，投稿界面已经显示接收了，但是仍然没有收到邮件的情况吗？这两者之间会有延迟吗？

36 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1013352, encodeId=bba7101335213, content=有谁近期关于医学的,写中国医院投稿过的，都一头棒据掉吗，还是也有审稿的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef9a5219936, createdName=14779ba9m13暂无昵称, createdTime=Wed Sep 01 02:15:38 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013153, encodeId=75be10131536f, content=偏重的研究方向：肿瘤 经验分享：期刊对创新性要求高嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Aug 31 11:21:27 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012560, encodeId=bea6101256028, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cd52485833, createdName=1246a6fdm27暂无昵称, createdTime=Sun Aug 29 14:23:23 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974186, encodeId=bbc59e4186d7, content=请问接收付完款后状态多久会改变呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5Rzft24cdjpft6PcWribvIeHZAd5rYELzpKhbFYdIicZfcDx0zFI7AmAHIcLNgb43KDWCg0nWcgic0Ape/0, createdBy=bcf42056335, createdName=157****3710, createdTime=Wed Jun 16 20:25:37 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010704, encodeId=5d0b1010e041a, content=请问各位有遇到过，投稿界面已经显示接收了，但是仍然没有收到邮件的情况吗？这两者之间会有延迟吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Us0GFMljsgJU8D7ARU18PgytwJjuyDS9CkTgwbYCsmj14TKlf7Hrx3T5lUvwLOoibhyXiaicME34sxTOpa0ibcic7bg/132, createdBy=628b5361344, createdName=阿标2359, createdTime=Mon Aug 23 20:09:19 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009177, encodeId=9fce10091e764, content=偏重的研究方向：肿瘤 经验分享：请问大家，两个review is ongoing是指有两个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Wed Aug 18 16:40:48 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007220, encodeId=1982100e22037, content=各位大佬们，生信分析+一点临床测序的数据，可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Aug 12 10:29:26 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973820, encodeId=5e5e9e38203b, content=接受到在online请问要多久？最近需要一篇文章，不知道能不能来得及。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210614/2fd7d17bfe3e4ff9897456da2862f2bc/5d601b07dfb64fdf863f473a3f3d0cf0.jpg, createdBy=102e2533312, createdName=请叫我小硕, createdTime=Tue Jun 15 18:29:15 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007332, encodeId=e98d100e332fa, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享： 04 Aug 2021 Typesetting initiated. Production Office Frontiers Production Office uploaded file(s). 03 Aug 2021 Article accepted for publication. 02 Aug 2021 Review of Review Editor 1 finalized. 28 Jul 2021 Review of Review Editor 3 finalized. 20 Jul 2021 Submitting Author re-submitted manuscript. You posted new comments. 21 Jun 2021 Interactive review forum activated. 30 Apr 2021 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8e85475215, createdName=神力武叨叨, createdTime=Thu Aug 12 17:32:09 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003043, encodeId=525e100304377, content=请问一直在Editorial Assignment 这个状态多久才能催稿啊，一直没有分配编辑，给哪个邮箱发邮件催啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28125557864, createdName=ms5000002114037359, createdTime=Tue Jul 27 16:22:48 CST 2021, time=2021-07-27, status=1, ipAttribution=)]

2021-08-18 122220a4m01暂无昵称

偏重的研究方向：肿瘤
经验分享：请问大家，两个review is ongoing是指有两个审稿人？

37 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1013352, encodeId=bba7101335213, content=有谁近期关于医学的,写中国医院投稿过的，都一头棒据掉吗，还是也有审稿的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef9a5219936, createdName=14779ba9m13暂无昵称, createdTime=Wed Sep 01 02:15:38 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013153, encodeId=75be10131536f, content=偏重的研究方向：肿瘤 经验分享：期刊对创新性要求高嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Aug 31 11:21:27 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012560, encodeId=bea6101256028, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cd52485833, createdName=1246a6fdm27暂无昵称, createdTime=Sun Aug 29 14:23:23 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974186, encodeId=bbc59e4186d7, content=请问接收付完款后状态多久会改变呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5Rzft24cdjpft6PcWribvIeHZAd5rYELzpKhbFYdIicZfcDx0zFI7AmAHIcLNgb43KDWCg0nWcgic0Ape/0, createdBy=bcf42056335, createdName=157****3710, createdTime=Wed Jun 16 20:25:37 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010704, encodeId=5d0b1010e041a, content=请问各位有遇到过，投稿界面已经显示接收了，但是仍然没有收到邮件的情况吗？这两者之间会有延迟吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Us0GFMljsgJU8D7ARU18PgytwJjuyDS9CkTgwbYCsmj14TKlf7Hrx3T5lUvwLOoibhyXiaicME34sxTOpa0ibcic7bg/132, createdBy=628b5361344, createdName=阿标2359, createdTime=Mon Aug 23 20:09:19 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009177, encodeId=9fce10091e764, content=偏重的研究方向：肿瘤 经验分享：请问大家，两个review is ongoing是指有两个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Wed Aug 18 16:40:48 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007220, encodeId=1982100e22037, content=各位大佬们，生信分析+一点临床测序的数据，可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Aug 12 10:29:26 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973820, encodeId=5e5e9e38203b, content=接受到在online请问要多久？最近需要一篇文章，不知道能不能来得及。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210614/2fd7d17bfe3e4ff9897456da2862f2bc/5d601b07dfb64fdf863f473a3f3d0cf0.jpg, createdBy=102e2533312, createdName=请叫我小硕, createdTime=Tue Jun 15 18:29:15 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007332, encodeId=e98d100e332fa, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享： 04 Aug 2021 Typesetting initiated. Production Office Frontiers Production Office uploaded file(s). 03 Aug 2021 Article accepted for publication. 02 Aug 2021 Review of Review Editor 1 finalized. 28 Jul 2021 Review of Review Editor 3 finalized. 20 Jul 2021 Submitting Author re-submitted manuscript. You posted new comments. 21 Jun 2021 Interactive review forum activated. 30 Apr 2021 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8e85475215, createdName=神力武叨叨, createdTime=Thu Aug 12 17:32:09 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003043, encodeId=525e100304377, content=请问一直在Editorial Assignment 这个状态多久才能催稿啊，一直没有分配编辑，给哪个邮箱发邮件催啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28125557864, createdName=ms5000002114037359, createdTime=Tue Jul 27 16:22:48 CST 2021, time=2021-07-27, status=1, ipAttribution=)]

2021-08-12 持勤

各位大佬们，生信分析+一点临床测序的数据，可以投嘛？

36 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1013352, encodeId=bba7101335213, content=有谁近期关于医学的,写中国医院投稿过的，都一头棒据掉吗，还是也有审稿的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef9a5219936, createdName=14779ba9m13暂无昵称, createdTime=Wed Sep 01 02:15:38 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013153, encodeId=75be10131536f, content=偏重的研究方向：肿瘤 经验分享：期刊对创新性要求高嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Aug 31 11:21:27 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012560, encodeId=bea6101256028, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cd52485833, createdName=1246a6fdm27暂无昵称, createdTime=Sun Aug 29 14:23:23 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974186, encodeId=bbc59e4186d7, content=请问接收付完款后状态多久会改变呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5Rzft24cdjpft6PcWribvIeHZAd5rYELzpKhbFYdIicZfcDx0zFI7AmAHIcLNgb43KDWCg0nWcgic0Ape/0, createdBy=bcf42056335, createdName=157****3710, createdTime=Wed Jun 16 20:25:37 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010704, encodeId=5d0b1010e041a, content=请问各位有遇到过，投稿界面已经显示接收了，但是仍然没有收到邮件的情况吗？这两者之间会有延迟吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Us0GFMljsgJU8D7ARU18PgytwJjuyDS9CkTgwbYCsmj14TKlf7Hrx3T5lUvwLOoibhyXiaicME34sxTOpa0ibcic7bg/132, createdBy=628b5361344, createdName=阿标2359, createdTime=Mon Aug 23 20:09:19 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009177, encodeId=9fce10091e764, content=偏重的研究方向：肿瘤 经验分享：请问大家，两个review is ongoing是指有两个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Wed Aug 18 16:40:48 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007220, encodeId=1982100e22037, content=各位大佬们，生信分析+一点临床测序的数据，可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Aug 12 10:29:26 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973820, encodeId=5e5e9e38203b, content=接受到在online请问要多久？最近需要一篇文章，不知道能不能来得及。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210614/2fd7d17bfe3e4ff9897456da2862f2bc/5d601b07dfb64fdf863f473a3f3d0cf0.jpg, createdBy=102e2533312, createdName=请叫我小硕, createdTime=Tue Jun 15 18:29:15 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007332, encodeId=e98d100e332fa, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享： 04 Aug 2021 Typesetting initiated. Production Office Frontiers Production Office uploaded file(s). 03 Aug 2021 Article accepted for publication. 02 Aug 2021 Review of Review Editor 1 finalized. 28 Jul 2021 Review of Review Editor 3 finalized. 20 Jul 2021 Submitting Author re-submitted manuscript. You posted new comments. 21 Jun 2021 Interactive review forum activated. 30 Apr 2021 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8e85475215, createdName=神力武叨叨, createdTime=Thu Aug 12 17:32:09 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003043, encodeId=525e100304377, content=请问一直在Editorial Assignment 这个状态多久才能催稿啊，一直没有分配编辑，给哪个邮箱发邮件催啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28125557864, createdName=ms5000002114037359, createdTime=Tue Jul 27 16:22:48 CST 2021, time=2021-07-27, status=1, ipAttribution=)]

2021-06-15 请叫我小硕

接受到在online请问要多久？最近需要一篇文章，不知道能不能来得及。

64 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1013352, encodeId=bba7101335213, content=有谁近期关于医学的,写中国医院投稿过的，都一头棒据掉吗，还是也有审稿的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef9a5219936, createdName=14779ba9m13暂无昵称, createdTime=Wed Sep 01 02:15:38 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013153, encodeId=75be10131536f, content=偏重的研究方向：肿瘤 经验分享：期刊对创新性要求高嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Aug 31 11:21:27 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012560, encodeId=bea6101256028, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cd52485833, createdName=1246a6fdm27暂无昵称, createdTime=Sun Aug 29 14:23:23 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974186, encodeId=bbc59e4186d7, content=请问接收付完款后状态多久会改变呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5Rzft24cdjpft6PcWribvIeHZAd5rYELzpKhbFYdIicZfcDx0zFI7AmAHIcLNgb43KDWCg0nWcgic0Ape/0, createdBy=bcf42056335, createdName=157****3710, createdTime=Wed Jun 16 20:25:37 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010704, encodeId=5d0b1010e041a, content=请问各位有遇到过，投稿界面已经显示接收了，但是仍然没有收到邮件的情况吗？这两者之间会有延迟吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Us0GFMljsgJU8D7ARU18PgytwJjuyDS9CkTgwbYCsmj14TKlf7Hrx3T5lUvwLOoibhyXiaicME34sxTOpa0ibcic7bg/132, createdBy=628b5361344, createdName=阿标2359, createdTime=Mon Aug 23 20:09:19 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009177, encodeId=9fce10091e764, content=偏重的研究方向：肿瘤 经验分享：请问大家，两个review is ongoing是指有两个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Wed Aug 18 16:40:48 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007220, encodeId=1982100e22037, content=各位大佬们，生信分析+一点临床测序的数据，可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Aug 12 10:29:26 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973820, encodeId=5e5e9e38203b, content=接受到在online请问要多久？最近需要一篇文章，不知道能不能来得及。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210614/2fd7d17bfe3e4ff9897456da2862f2bc/5d601b07dfb64fdf863f473a3f3d0cf0.jpg, createdBy=102e2533312, createdName=请叫我小硕, createdTime=Tue Jun 15 18:29:15 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007332, encodeId=e98d100e332fa, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享： 04 Aug 2021 Typesetting initiated. Production Office Frontiers Production Office uploaded file(s). 03 Aug 2021 Article accepted for publication. 02 Aug 2021 Review of Review Editor 1 finalized. 28 Jul 2021 Review of Review Editor 3 finalized. 20 Jul 2021 Submitting Author re-submitted manuscript. You posted new comments. 21 Jun 2021 Interactive review forum activated. 30 Apr 2021 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8e85475215, createdName=神力武叨叨, createdTime=Thu Aug 12 17:32:09 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003043, encodeId=525e100304377, content=请问一直在Editorial Assignment 这个状态多久才能催稿啊，一直没有分配编辑，给哪个邮箱发邮件催啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28125557864, createdName=ms5000002114037359, createdTime=Tue Jul 27 16:22:48 CST 2021, time=2021-07-27, status=1, ipAttribution=)]

2021-08-12 神力武叨叨

审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0
偏重的研究方向：肿瘤
经验分享：
04 Aug 2021 Typesetting initiated.
Production Office Frontiers Production Office uploaded file(s).
03 Aug 2021 Article accepted for publication.
02 Aug 2021 Review of Review Editor 1 finalized.
28 Jul 2021 Review of Review Editor 3 finalized.
20 Jul 2021 Submitting Author re-submitted manuscript.
You posted new comments.
21 Jun 2021 Interactive review forum activated.
30 Apr 2021 Submitting Author submitted manuscript.

39 0

[GetPortalCommentsPageByObjectIdResponse(id=1013352, encodeId=bba7101335213, content=有谁近期关于医学的,写中国医院投稿过的，都一头棒据掉吗，还是也有审稿的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef9a5219936, createdName=14779ba9m13暂无昵称, createdTime=Wed Sep 01 02:15:38 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013153, encodeId=75be10131536f, content=偏重的研究方向：肿瘤 经验分享：期刊对创新性要求高嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Aug 31 11:21:27 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012560, encodeId=bea6101256028, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cd52485833, createdName=1246a6fdm27暂无昵称, createdTime=Sun Aug 29 14:23:23 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974186, encodeId=bbc59e4186d7, content=请问接收付完款后状态多久会改变呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5Rzft24cdjpft6PcWribvIeHZAd5rYELzpKhbFYdIicZfcDx0zFI7AmAHIcLNgb43KDWCg0nWcgic0Ape/0, createdBy=bcf42056335, createdName=157****3710, createdTime=Wed Jun 16 20:25:37 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010704, encodeId=5d0b1010e041a, content=请问各位有遇到过，投稿界面已经显示接收了，但是仍然没有收到邮件的情况吗？这两者之间会有延迟吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Us0GFMljsgJU8D7ARU18PgytwJjuyDS9CkTgwbYCsmj14TKlf7Hrx3T5lUvwLOoibhyXiaicME34sxTOpa0ibcic7bg/132, createdBy=628b5361344, createdName=阿标2359, createdTime=Mon Aug 23 20:09:19 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009177, encodeId=9fce10091e764, content=偏重的研究方向：肿瘤 经验分享：请问大家，两个review is ongoing是指有两个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Wed Aug 18 16:40:48 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007220, encodeId=1982100e22037, content=各位大佬们，生信分析+一点临床测序的数据，可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Aug 12 10:29:26 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973820, encodeId=5e5e9e38203b, content=接受到在online请问要多久？最近需要一篇文章，不知道能不能来得及。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210614/2fd7d17bfe3e4ff9897456da2862f2bc/5d601b07dfb64fdf863f473a3f3d0cf0.jpg, createdBy=102e2533312, createdName=请叫我小硕, createdTime=Tue Jun 15 18:29:15 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007332, encodeId=e98d100e332fa, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享： 04 Aug 2021 Typesetting initiated. Production Office Frontiers Production Office uploaded file(s). 03 Aug 2021 Article accepted for publication. 02 Aug 2021 Review of Review Editor 1 finalized. 28 Jul 2021 Review of Review Editor 3 finalized. 20 Jul 2021 Submitting Author re-submitted manuscript. You posted new comments. 21 Jun 2021 Interactive review forum activated. 30 Apr 2021 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8e85475215, createdName=神力武叨叨, createdTime=Thu Aug 12 17:32:09 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003043, encodeId=525e100304377, content=请问一直在Editorial Assignment 这个状态多久才能催稿啊，一直没有分配编辑，给哪个邮箱发邮件催啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28125557864, createdName=ms5000002114037359, createdTime=Tue Jul 27 16:22:48 CST 2021, time=2021-07-27, status=1, ipAttribution=)]

2021-07-27 ms5000002114037359

请问一直在Editorial Assignment 这个状态多久才能催稿啊，一直没有分配编辑，给哪个邮箱发邮件催啊

41 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务